Clinical trial
Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus
NCT00008749 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00008749 |
|---|---|
| Title | Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus |
| Official title | Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Arthritis Foundation |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Lupus Erythematosus, Systemic |
| First posted | Jan 18, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: